{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:46:01Z","timestamp":1792273561042,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503697"],"award-info":[{"award-number":["82503697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20250230"],"award-info":[{"award-number":["BX20250230"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN25H160024"],"award-info":[{"award-number":["LQN25H160024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H160017"],"award-info":[{"award-number":["LQN26H160017"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025699757"],"award-info":[{"award-number":["2025699757"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782264"],"award-info":[{"award-number":["2025M782264"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762871"],"award-info":[{"award-number":["2024M762871"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03176"],"award-info":[{"award-number":["2024C03176"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02062"],"award-info":[{"award-number":["2025C02062"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12072-026-11111-6","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:25:45Z","timestamp":1781004345000},"page":"1479-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suppression of macrophage membrane cholesterol efflux by SLAMF7-induced IL-7 signaling improves immunotherapy efficacy in hepatocellular carcinoma"],"prefix":"10.1007","volume":"20","author":[{"given":"Jialei","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-0799","authenticated-orcid":false,"given":"Xiujun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"11111_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma Nat Rev Dis Primers. 2021;7:6","journal-title":"Hepatocellular carcinoma Nat Rev Dis Primers"},{"key":"11111_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14: 1133308","journal-title":"Front Immunol"},{"key":"11111_CR3","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/s41388-023-02757-9","volume":"42","author":"J Hu","year":"2023","unstructured":"Hu J, Liu N, Song D, Steer CJ, Zheng G, Song G. A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma. Oncogene. 2023;42:2892\u20132904","journal-title":"Oncogene"},{"issue":"11","key":"11111_CR4","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-23-2889","volume":"84","author":"S Wan","year":"2024","unstructured":"Wan S, He QY, Yang Y, Liu F, Zhang X, Guo X, et al. SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma. Cancer Res. 2024;84(11):1872\u20131888","journal-title":"Cancer Res"},{"key":"11111_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101144","volume":"4","author":"Y Pan","year":"2023","unstructured":"Pan Y, Chen H, Zhang X, Liu W, Ding Y, Huang D, et al. METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep Med. 2023;4: 101144","journal-title":"Cell Rep Med"},{"key":"11111_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","volume":"19","author":"W Tang","year":"2022","unstructured":"Tang W, Zhou J, Yang W, Feng Y, Wu H, Mok MTS, et al. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver. Cell Mol Immunol. 2022;19:834\u2013847","journal-title":"Cell Mol Immunol"},{"key":"11111_CR7","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1158\/2326-6066.CIR-22-0907","volume":"11","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Y, Xing R, Zeng H, Yu XJ, Zhang YJ, et al. Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of human hepatocellular carcinoma. Cancer Immunol Res. 2023;11:1400\u20131413","journal-title":"Cancer Immunol Res"},{"key":"11111_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1324140","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Liu C, Hu R, Wu L, Li C. Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma. Front Pharmacol. 2024;15: 1324140","journal-title":"Front Pharmacol"},{"key":"11111_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3348","author":"A Cachot","year":"2021","unstructured":"Cachot A, Bilous M, Liu YC, Li X, Saillard M, Cenerenti M, et al. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abe3348","journal-title":"Sci Adv"},{"key":"11111_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature22076","volume":"544","author":"J Chen","year":"2017","unstructured":"Chen J, Zhong MC, Guo H, Davidson D, Mishel S, Lu Y, et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493\u2013497","journal-title":"Nature"},{"key":"11111_CR11","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/S2352-3026(23)00366-6","volume":"11","author":"EK Mai","year":"2024","unstructured":"Mai EK, Goldschmid H, Miah K, Bertsch U, Besemer B, H\u00e4nel M, et al. Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial. Lancet Haematol. 2024;11:e101\u2013e113","journal-title":"Lancet Haematol"},{"key":"11111_CR12","first-page":"4721","volume":"12","author":"SH Wang","year":"2022","unstructured":"Wang SH, Chou WC, Huang HC, Lee TA, Hsiao TC, Wang LH, et al. Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis. Am J Cancer Res. 2022;12:4721\u20134736","journal-title":"Am J Cancer Res"},{"issue":"11","key":"11111_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","volume":"84","author":"J Weng","year":"2024","unstructured":"Weng J, Wang Z, Hu Z, Xu W, Sun JL, Wang F, et al. Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer Res. 2024;84(11):1817\u20131833","journal-title":"Cancer Res"},{"key":"11111_CR14","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","volume":"29","author":"P Goossens","year":"2019","unstructured":"Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 2019;29:1376\u201389.e4","journal-title":"Cell Metab"},{"key":"11111_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s43556-025-00321-3","volume":"6","author":"D Cui","year":"2025","unstructured":"Cui D, Yu X, Guan Q, Shen Y, Liao J, Liu Y, et al. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6:72","journal-title":"Mol Biomed"},{"key":"11111_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1042\/BCJ20190647","volume":"477","author":"NA Scott","year":"2020","unstructured":"Scott NA, Sharpe LJ, Capell-Hattam IM, Gullo SJ, Luu W, Brown AJ. The cholesterol synthesis enzyme lanosterol 14\u03b1-demethylase is post-translationally regulated by the E3 ubiquitin ligase MARCH6. Biochem J. 2020;477:541\u2013555","journal-title":"Biochem J"},{"key":"11111_CR17","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1074\/jbc.M113.449918","volume":"288","author":"B Tamarit","year":"2013","unstructured":"Tamarit B, Bugault F, Pillet AH, Lavergne V, Bochet P, Garin N, et al. Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells. J Biol Chem. 2013;288:8691\u20138701","journal-title":"J Biol Chem"},{"key":"11111_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell. 2019;36:418\u201330.e6","journal-title":"Cancer Cell"},{"key":"11111_CR19","doi-asserted-by":"publisher","first-page":"1538472","DOI":"10.3389\/fmolb.2025.1538472","volume":"12","author":"Y Asadi","year":"2025","unstructured":"Asadi Y, Moundounga RK, Chakroborty A, Pokokiri A, Wang H. FOXOs and their roles in acute and chronic neurological disorders. Front Mol Biosci. 2025;12:1538472","journal-title":"Front Mol Biosci"},{"key":"11111_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41419-023-05987-7","volume":"14","author":"R Xu","year":"2023","unstructured":"Xu R, Song J, Ruze R, Chen Y, Yin X, Wang C, et al. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src\/PI3K\/Akt signaling pathway. Cell Death Dis. 2023;14:497","journal-title":"Cell Death Dis"},{"key":"11111_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1158\/2159-8290.CD-21-0551","volume":"12","author":"M Rashkovan","year":"2022","unstructured":"Rashkovan M, Albero R, Gianni F, Perez-Duran P, Miller HI, Mackey AL, et al. Intracellular cholesterol pools regulate oncogenic signaling and epigenetic circuitries in early T-cell precursor acute lymphoblastic leukemia. Cancer Discov. 2022;12:856\u2013871","journal-title":"Cancer Discov"},{"key":"11111_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14111362","author":"KD Laguna-Maldonado","year":"2025","unstructured":"Laguna-Maldonado KD, Uribe-Ram\u00edrez D, V\u00e1zquez-Carrada M, Matuz-Mares D, Vilchis-Landeros MM. Dysfunction of the ABCA1 and ABCG1 transporters and their impact on HDL metabolism. Antioxidants Basel. 2025. https:\/\/doi.org\/10.3390\/antiox14111362","journal-title":"Antioxidants Basel"},{"key":"11111_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12:558\u2013580","journal-title":"Acta Pharm Sin B"},{"key":"11111_CR24","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068\u201383.e23","journal-title":"Cell"},{"key":"11111_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u2013257","journal-title":"Nature"},{"key":"11111_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150224","author":"Y Wu","year":"2023","unstructured":"Wu Y, Wang Q, Li M, Lao J, Tang H, Ming S, et al. SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI150224","journal-title":"J Clin Invest"},{"key":"11111_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110574","volume":"280","author":"G Luo","year":"2025","unstructured":"Luo G, Ni R, Huang X, Li Y, Luo D. The role of signaling lymphocytic activation molecule (SLAM) family receptors in health and disease progression: focusing on cancer and therapy. Clin Immunol. 2025;280: 110574","journal-title":"Clin Immunol"},{"key":"11111_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.04.028","volume":"122","author":"XE Tang","year":"2019","unstructured":"Tang XE, Li H, Chen LY, Xia XD, Zhao ZW, Zheng XL, et al. IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells. Cytokine. 2019;122: 154385","journal-title":"Cytokine"},{"key":"11111_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajpath.2015.12.023","volume":"186","author":"K Gabunia","year":"2016","unstructured":"Gabunia K, Ellison S, Kelemen S, Kako F, Cornwell WD, Rogers TJ, et al. IL-19 Halts progression of atherosclerotic plaque, polarizes, and increases cholesterol uptake and Efflux in macrophages. Am J Pathol. 2016;186:1361\u20131374","journal-title":"Am J Pathol"},{"key":"11111_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36:346\u2013351","journal-title":"Nat Biotechnol"},{"key":"11111_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nm.1953","volume":"15","author":"M Pellegrini","year":"2009","unstructured":"Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med. 2009;15:528\u2013536","journal-title":"Nat Med"},{"key":"11111_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18137","volume":"28","author":"S Zhang","year":"2024","unstructured":"Zhang S, Ma J, Yu T, Song Z, Lau WY, Zha Y. circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR-338-5p\/IL-7 pathway. J Cell Mol Med. 2024;28: e18137","journal-title":"J Cell Mol Med"},{"key":"11111_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cyto.2018.04.003","volume":"118","author":"D Teng","year":"2019","unstructured":"Teng D, Ding L, Cai B, Luo Q, Wang H. Interleukin-7 enhances anti-tumor activity of CD8(+) T cells in patients with hepatocellular carcinoma. Cytokine. 2019;118:115\u2013123","journal-title":"Cytokine"},{"key":"11111_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01128-9","volume":"14","author":"N Pang","year":"2021","unstructured":"Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, et al. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. J Hematol Oncol. 2021;14: 118","journal-title":"J Hematol Oncol"},{"key":"11111_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejca.2022.04.035","volume":"172","author":"M Santoni","year":"2022","unstructured":"Santoni M, Massari F, Matrana MR, Basso U, De Giorgi U, Aurilio G, et al. Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. Eur J Cancer. 2022;172:191\u2013198","journal-title":"Eur J Cancer"},{"key":"11111_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09385-8","volume":"22","author":"K Takada","year":"2022","unstructured":"Takada K, Shimokawa M, Takamori S, Shimamatsu S, Hirai F, Tagawa T, et al. A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study. BMC Cancer. 2022;22: 503","journal-title":"BMC Cancer"},{"key":"11111_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01205-8","volume":"20","author":"Z Yu","year":"2022","unstructured":"Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, et al. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. J Nanobiotechnology. 2022;20: 9","journal-title":"J Nanobiotechnology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11111-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:18:55Z","timestamp":1792271935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11111-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11111"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11111-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethics Committee of the Sir Run-Run Shaw Hospital (approval No. 2025-1229) and all patients involved signed written informed consent. This study was conducted in accordance with both the Declarations of Helsinki and Istanbul.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}